Navigation Links
Governor O'Malley Announces $200 Million Investment In Maryland By Top Brazilian Pharmaceutical Company
Date:12/3/2013

ANNAPOLIS, Md., Dec. 3, 2013 /PRNewswire-USNewswire/ -- On a trade mission to Brazil, Governor Martin O'Malley today announced that Brace Pharmaceuticals, an investment company created by EMS S/A, Brazil's largest domestic pharmaceutical company, has opened its U.S. headquarters in Montgomery County and plans to invest $200 million into the new operation. The company, which is located in the Rockville Innovation Center, is focused on the late stage clinical development of pharmaceutical products with the potential for near-term commercialization. Brace invests in research and development companies' efforts to successfully complete their clinical trials and seek FDA marketing approval. Brace recently entered into its first venture investment in a U.S. company with Gliknik, a Baltimore-based biopharmaceutical company that is creating new therapies for cancer and immune disorders. The announcement came after Governor O'Malley visited EMS headquarters near Sao Paulo and met with the company's owner and Chairman, Carlos Sanchez and its Vice President of Strategy & Operations, Vinzenz Plorer, a member of the Maryland delegation to Brazil.

(Photo: http://photos.prnewswire.com/prnh/20131203/DC27090)

"Brace Pharmaceuticals' decision to establish its U.S. headquarters in Maryland reaffirms the State's position as one of the world's leading locations for life sciences innovation," said Governor O'Malley. "We welcome Brace and are pleased that they will be able to benefit from our highly-educated workforce and our proximity to key federal labs. Their work with a wealth of cutting-edge companies will help to cure diseases and develop new therapies to save lives across the globe." 

"By establishing Brace's operations in Rockville, Maryland, we have access to one of the U.S.'s top life sciences communities," Brace's Plorer said. "There is a talented pool of industry experience to draw upon as we expand our footprint. Moreover, there is established infrastructure and support from companies, universities, NIH and FDA."

Governor O'Malley also announced that DK Diagnostics, a Sao Paulo, Brazil-based biotechnology company, is planning to expand its presence in Maryland, invest $1 million in the new operation and grow to 20 employees over the next two years. Founded in 2004, the company manufactures and markets a parasite testing kit called PARATEST. Currently, the company has four employees in an office in Frederick and recently began manufacturing the product in Maryland.

"It is our goal to become an export company to NAFTA's market from our plant in Maryland and help fortify the concept of biotechnological innovation that is the State's mark," said Jose Carlos Lapenna, DK Diagnostic President & CEO.

Earlier today, Governor O'Malley addressed the Federation of Industries of Sao Paulo, which represents more than 30,000 industrial companies. As part of the presentation, called "Doing Business in Maryland," the Governor highlighted the State's top-ranked education system and leadership in the Innovation Economy, including biotechnology, cyber security and advanced manufacturing.

About EMS
EMS is the largest pharmaceutical company in Brazil, and the second largest pharmaceutical company in Latin America. With a 50-year corporate history, EMS focuses on over 2,500 prescription, generic, branded generic, and over-the-counter products for a wide variety of indications. EMS has full production capabilities, including manufacturing, packaging and quality control, as well as state-of-the-art research and development facilities. EMS is continually expanding its capacity through internally-funded investment in its core competences. In 2013, EMS formed Brace Pharma to invest in pharmaceutical innovation in the United States and to expand global efforts for development and commercialization. For additional information, please visit www.ems.com.br.

About Brace Pharma
Brace Pharma is the U.S. investment company of EMS, Brazil's largest pharmaceutical company. Brace Pharma invests in companies developing innovative therapies for life threatening diseases with insufficient treatment options. Brace Pharma's partnership model funds late stage clinical programs with the potential for commercialization within three to five years. For additional information, visit www.bracepharma.com.


'/>"/>
SOURCE Office of Governor O'Malley
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Governor-General of Australia Ms. Bryce Visits Sichuan University and Investigates Australia Cochlear Cochlea Project in West China Hospital, Sichuan University
2. Governor Jan Brewer Signs Arizonas Epinephrine Bill into Law Before Roomful of Advocates
3. PA Governor Corbett: Americure Rx Establishes Operations in Lehigh Valley; Creates 51 Jobs
4. Pennsylvania Governor Corbett: Specialized Medical Company to Relocate Headquarters and Customer Service Center
5. Governor Corbett Visits Life Science Employers in the Southeast, Holds Town Hall with Employees
6. Governor Chris Christies Surprise Gastric Bypass Has Americans Talking about Health: What Are Less Drastic Ways to Stay Lean and Prevent Cardio Risks?
7. CHPA Applauds Governor Mike Pence and the Passage of SB 496
8. Connecticut Governor Dannel P. Malloy, U.S. Senator Richard Blumenthal Open StemCONN 2013
9. Health Diagnostic Laboratory, Inc. hosts Town Hall Meeting with Governor Tim Kaine and Senator Mark Warner
10. Governor Corbett: Pharmaceutical and Medical Device Packaging Company to Create New Jobs in Lehigh Valley
11. Governor Corbett: Lancaster County Commercial Lab to Expand, Create 200 New Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):